LOCAL CARE. REAL RESULTS.
WEIGHT LOSS
A HEALTHIER, HAPPIER YOU STARTS NOW.
Transform your health with our comprehensive weight loss program. Our provider-led approach combines medication, ongoing support, and personalized care to help you achieve lasting results.
*Program requires a 4-month minimum commitment. Pricing subject to change. Consult with your provider for eligibility.
PROVIDER-LED CARE & ONGOING SUPPORT
MEDICATION & SUPPLIES INCLUDED
MONTHLY VITAMIN IM TO SUPPORT RESULTS
PERSONALIZED CARE YOU CAN COUNT ON
Feel your best.
WE'RE HERE TO HELP YOU GET THERE.
THE ABELLA ADVANTAGE
Experience the difference with our personalized approach to aesthetic treatments.
- Expert medical professionals with years of experience
- Personalized treatment plans tailored to your goals
- Up front pricing
- Comfortable and welcoming environment
- Comprehensive aftercare and support
All you need to know
Semaglutide is a medication classified as a glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily used in the management of type 2 diabetes mellitus and, more recently, for weight management. Semaglutide works by mimicking the action of natural GLP-1 hormones in the body, which helps regulate blood sugar levels, promotes insulin secretion, reduces appetite, and slows down gastric emptying. This multifaceted action makes semaglutide effective in controlling blood sugar levels in diabetic patients and aiding in weight loss for individuals struggling with obesity. It is typically administered as a once-weekly injection.
Tirzepatide is a next-generation GLP-1/GIP medication that helps reduce hunger, control cravings, improve blood sugar regulation, and support significant, sustained weight loss. It is administered once weekly through a small injection.
- REDUCING HUNGER
- CONTROLLING APPETITE
- DELAYING GASTRIC EMPTYING
- AND INDUCING A SENSE OF FULLNESS AFTER MEALS
It signals your brain that you are full so you can loose weight without feeling like you are depriving yourself.
- < 18 years old
- Pregnant/breastfeeding
- Type 1 diabetes mellitus
- Hypersensitivity to semaglutide or any components of this medication
- Personal or family history of medullary thyroid carcinoma
- History of multiple endocrine neoplasia syndrome
- History of pancreatitis
- End stage renal disease (on dialysis)
- BMI<25
- Type 2 diabetic patients that are on insulin or a sulfonylurea
- Patients with diabetic retinopathy
- Patients that are on several antihypertensive medications
Yes, semaglutide and Ozempic are closely related, but they are not exactly the same. Semaglutide is the active ingredient found in Ozempic. Ozempic is a brand name medication that contains semaglutide as its active pharmaceutical ingredient (API). It is used for the treatment of type 2 diabetes. Semaglutide works by mimicking the action of a hormone called glucagon-like peptide 1 (GLP-1), which helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion.
So, while semaglutide is the generic name of the medication, Ozempic is one of the brand names under which it is sold. There may be other brand names for medications containing semaglutide as well.
- Reversal of diabetes
- Cholesterol reduction
- Normalization of blood pressure
- Proven Reduction in heart disease
- Proven Reduction in stroke risk
Both medications are highly effective for weight loss, but they work slightly differently.
Semaglutide targets the GLP-1 pathway to reduce hunger and increase fullness.
Tirzepatide targets both GLP-1 and GIP pathways, offering enhanced appetite control and improved metabolic support—which may lead to faster results for some clients.
Your Abella medical provider will evaluate your goals, medical history, and response to previous treatments to determine which option is the safest and most effective for you.